CompareMarketResearchRequest a sample
Home / Healthcare / Precision Medicine

Healthcare · Market report

Precision Medicine Market Size, Share and Forecast 2026-2036

The global precision medicine market is worth USD 42.2 bn in 2026 and is forecast to reach USD 120 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Tumour profiling and liquid biopsy is the largest by product segment.

USD 42.2 bnMarket size 2026
USD 120 bnForecast 2036
11.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global precision medicine market is worth USD 42.2 bn in 2026 and is forecast to reach USD 120 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Tumour profiling and liquid biopsy is the largest by product segment.

ScopeDiagnostic tests, companion diagnostics, pharmacogenomic tests and bioinformatics services used to select treatment based on a patient's genetic or molecular profile, excluding the drugs themselves.
IndustryHealthcare
Value 2025USD 38.0 bn
Value 2026USD 42.2 bn
Value 2036USD 120 bn
CAGR 2026-203611.0%
Volume 2026314 million tests
Volume 2036986 million tests
Average price 2026USD 134 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Precision Medicine market size and forecast, 2026-2036

Exhibit 1The global precision medicine market is forecast to grow from USD 42.2 bn in 2026 to USD 120 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 11.0%
Precision Medicine market value, 2025 to 2036Market value by year. 2025: USD 38.0 bn; 2026: USD 42.2 bn; 2027: USD 46.8 bn; 2028: USD 52.0 bn; 2029: USD 57.7 bn; 2030: USD 64.0 bn; 2031: USD 71.1 bn; 2032: USD 78.9 bn; 2033: USD 87.6 bn; 2034: USD 97.2 bn; 2035: USD 108 bn; 2036: USD 120 bn. Compound annual growth rate 2026 to 2036: 11.0%.202542.2 bn202671.1 bn2031120 bn203611.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 42.2 bn
2027USD 46.8 bn
2028USD 52.0 bn
2029USD 57.7 bn
2030USD 64.0 bn
2031USD 71.1 bn
2032USD 78.9 bn
2033USD 87.6 bn
2034USD 97.2 bn
2035USD 108 bn
2036USD 120 bn

Precision Medicine market segmentation

By product

Exhibit 2Tumour profiling and liquid biopsy is the largest segment by product, with 32.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Precision Medicine market share by product, 2026Share of 2026 revenue by product. Tumour profiling and liquid biopsy: 32.0%; Companion diagnostics: 24.0%; Genetic and carrier screening: 18.0%; Bioinformatics and data services: 16.0%; Pharmacogenomics: 10.0%.Tumour profiling and liquid biopsy32.0%Companion diagnostics24.0%Genetic and carrier screening18.0%Bioinformatics and data services16.0%Pharmacogenomics10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Companion diagnostics24.0%24.4%USD 10.1 bn11.2%
Tumour profiling and liquid biopsy32.0%38.8%USD 13.5 bn13.2%
Pharmacogenomics10.0%7.8%USD 4.2 bn8.2%
Genetic and carrier screening18.0%12.7%USD 7.6 bn7.2%
Bioinformatics and data services16.0%16.3%USD 6.7 bn11.2%

By application

Exhibit 3Oncology adds the most revenue by application, growing from USD 23.6 bn in 2026 to USD 73.4 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Precision Medicine market by application, 2026 and 2036Revenue by application in 2026 and 2036. Oncology: USD 23.6 bn in 2026, USD 73.4 bn in 2036, change +211%; Other: USD 7.6 bn in 2026, USD 18.8 bn in 2036, change +148%; Rare and inherited disease: USD 6.7 bn in 2026, USD 17.5 bn in 2036, change +160%; Cardiology and metabolic: USD 4.2 bn in 2026, USD 10.0 bn in 2036, change +137%.20262036 forecastChangeOncology+211%23.6 bn73.4 bnOther+148%7.6 bn18.8 bnRare and inherited disease+160%6.7 bn17.5 bnCardiology and metabolic+137%4.2 bn10.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Oncology56.0%61.3%USD 23.6 bn12.0%
Rare and inherited disease16.0%14.6%USD 6.7 bn10.0%
Cardiology and metabolic10.0%8.3%USD 4.2 bn9.0%
Other18.0%15.7%USD 7.6 bn9.5%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Next-generation sequencing38.0%42.0%USD 16.0 bn12.1%
PCR and qPCR24.0%20.0%USD 10.1 bn9.0%
Microarray10.0%7.0%USD 4.2 bn7.1%
Mass spectrometry12.0%12.0%USD 5.1 bn11.0%
Immunoassay and other16.0%19.0%USD 6.7 bn12.9%

By disease stage

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Screening and risk20.0%24.0%USD 8.4 bn13.0%
Diagnosis34.0%32.0%USD 14.3 bn10.3%
Treatment selection32.0%30.0%USD 13.5 bn10.3%
Monitoring14.0%14.0%USD 5.9 bn11.0%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals38.0%34.0%USD 16.0 bn9.8%
Diagnostic laboratories34.0%35.0%USD 14.3 bn11.3%
Pharma and biotech20.0%22.0%USD 8.4 bn12.1%
Research institutes8.0%9.0%USD 3.4 bn12.3%

Top 25 countries for precision medicine by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.5% of 2026 revenue and the 25 countries below together hold 96.5%.

Exhibit 4United States is the largest country market at USD 20.2 bn in 2026, and the three largest countries hold 64.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Precision Medicine market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 20.2 bn, 48.0%; China: USD 4.2 bn, 10.0%; Germany: USD 2.5 bn, 6.0%; Japan: USD 2.1 bn, 5.0%; United Kingdom: USD 1.9 bn, 4.5%; France: USD 1.7 bn, 4.0%; Italy: USD 1.3 bn, 3.0%; Canada: USD 1.1 bn, 2.5%; South Korea: USD 1.1 bn, 2.5%; Australia: USD 844 mn, 2.0%.United States20.2 bn 48.0%China4.2 bn 10.0%Germany2.5 bn 6.0%Japan2.1 bn 5.0%United Kingdom1.9 bn 4.5%France1.7 bn 4.0%Italy1.3 bn 3.0%Canada1.1 bn 2.5%South Korea1.1 bn 2.5%Australia844 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 20.2 bn48.0%USD 54.5 bn10.4%
2ChinaUSD 4.2 bn10.0%USD 16.2 bn14.4%
3GermanyUSD 2.5 bn6.0%USD 6.8 bn10.4%
4JapanUSD 2.1 bn5.0%USD 5.1 bn9.3%
5United KingdomUSD 1.9 bn4.5%USD 5.1 bn10.5%
6FranceUSD 1.7 bn4.0%USD 4.6 bn10.4%
7ItalyUSD 1.3 bn3.0%USD 3.2 bn9.8%
8CanadaUSD 1.1 bn2.5%USD 2.9 bn10.6%
9South KoreaUSD 1.1 bn2.5%USD 3.4 bn12.3%
10AustraliaUSD 844 mn2.0%USD 2.4 bn11.0%
11SpainUSD 818 mn1.9%USD 2.3 bn10.7%
12NetherlandsUSD 506 mn1.2%USD 1.3 bn10.2%
13SwitzerlandUSD 375 mn0.9%USD 994 mn10.2%
14TaiwanUSD 299 mn0.7%USD 802 mn10.4%
15BrazilUSD 253 mn0.6%USD 958 mn14.2%
16IsraelUSD 224 mn0.5%USD 838 mn14.1%
17IndiaUSD 198 mn0.5%USD 743 mn14.1%
18SwedenUSD 177 mn0.4%USD 479 mn10.5%
19SingaporeUSD 164 mn0.4%USD 623 mn14.2%
20BelgiumUSD 152 mn0.4%USD 407 mn10.4%
21DenmarkUSD 139 mn0.3%USD 371 mn10.3%
22MexicoUSD 131 mn0.3%USD 503 mn14.4%
23Saudi ArabiaUSD 122 mn0.3%USD 467 mn14.3%
24AustriaUSD 118 mn0.3%USD 311 mn10.2%
25TurkeyUSD 110 mn0.3%USD 419 mn14.3%
Rest of worldUSD 1.5 bn3.5%USD 4.0 bn10.6%
Exhibit 5United States and China account for 60% of the USD 77.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Precision Medicine market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 42.2 bn. United States: +USD 34.2 bn; China: +USD 12.0 bn; Germany: +USD 4.3 bn; United Kingdom: +USD 3.3 bn; Japan: +USD 3.0 bn; 20 other countries: +USD 18.2 bn; Rest of world: +USD 2.6 bn. Market value 2036: USD 120 bn.Market value 202642.2 bnUnited States+34.2 bnChina+12.0 bnGermany+4.3 bnUnited Kingdom+3.3 bnJapan+3.0 bn20 other countries+18.2 bnRest of world+2.6 bnMarket value 2036120 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • Exact Sciences
  • Labcorp
  • Quest Diagnostics
  • Agilent Technologies

Group 2: Regional and specialist players

  • Foundation Medicine
  • Guardant Health
  • Natera
  • QIAGEN
  • Myriad Genetics
  • Tempus AI
  • Veracyte
  • NeoGenomics
  • Adaptive Biotechnologies

Group 3: Emerging and niche players

  • Caris Life Sciences
  • BGI Genomics
  • GeneDx
  • Personalis
  • Burning Rock Biotech
  • Sophia Genetics
  • Freenome

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the precision medicine market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 11.0% is calculated from the resulting values.

The market is divided by product, by application, by technology, by disease stage, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the precision medicine market?

The global precision medicine market is estimated at USD 38.0 bn in 2025 and USD 42.2 bn in 2026.

How fast will the precision medicine market grow?

It is forecast to reach USD 120 bn by 2036, a compound annual growth rate of 11.0% from 2026, an increase of USD 77.6 bn.

Which country is the largest market for precision medicine?

United States is the largest market by revenue at USD 20.2 bn in 2026, 48.0% of the global total. The three largest countries together hold 64.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 14.4% a year from 2026 to 2036.

Which precision medicine segment is largest?

In the by product split, Tumour profiling and liquid biopsy is the largest segment with 32.0% of 2026 revenue.

Who are the leading precision medicine companies?

Global leaders include Roche, Thermo Fisher Scientific, Illumina, Exact Sciences.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Polymerase Chain Reaction Precision Transplant Medicine →

All Healthcare markets →

Request a sample